Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
In Vivo (Athens, Greece)
|
October 19, 2010
Metastatic medullary carcinoma of the vulva in a patient with MEN IIb syndrome
N Thomakos, A Rodolakis, N Akrivos, et al.
Chemotherapy
|
September 10, 1998
Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients
N Thomakos, S Maraki, T Liakakos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2007
The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy
R Athavale, N Thomakos, K Godfrey, et al.
The Journal of Reproductive Medicine
|
October 5, 2001
Previous cesarean section. A contraindication to vaginal hysterectomy?
Y M Poindexter, H Sangi-Haghpeykar, A N Poindexter, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 19, 2025
Added value of ophthalmic artery Doppler in prediction of pre-eclampsia: systematic review and meta-analysis
I Sapantzoglou, P Antsaklis, V Pergialiotis, et al.
Gynecologic Oncology
|
July 19, 2011
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience
A Bamias, A Karadimou, N Soupos, et al.
Journal of Ovarian Research
|
November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M Liontos, A Andrikopoulou, K Koutsoukos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2011
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor
A Bamias, M Sotiropoulou, F Zagouri, et al.
British Journal of Cancer
|
November 22, 2012
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
N G Gavalas, M Tsiatas, O Tsitsilonis, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
In Vivo (Athens, Greece)
|
October 19, 2010
Metastatic medullary carcinoma of the vulva in a patient with MEN IIb syndrome
N Thomakos, A Rodolakis, N Akrivos, et al.
Chemotherapy
|
September 10, 1998
Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients
N Thomakos, S Maraki, T Liakakos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2007
The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy
R Athavale, N Thomakos, K Godfrey, et al.
The Journal of Reproductive Medicine
|
October 5, 2001
Previous cesarean section. A contraindication to vaginal hysterectomy?
Y M Poindexter, H Sangi-Haghpeykar, A N Poindexter, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
August 19, 2025
Added value of ophthalmic artery Doppler in prediction of pre-eclampsia: systematic review and meta-analysis
I Sapantzoglou, P Antsaklis, V Pergialiotis, et al.
Gynecologic Oncology
|
July 19, 2011
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience
A Bamias, A Karadimou, N Soupos, et al.
Journal of Ovarian Research
|
November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M Liontos, A Andrikopoulou, K Koutsoukos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 4, 2011
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor
A Bamias, M Sotiropoulou, F Zagouri, et al.
British Journal of Cancer
|
November 22, 2012
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
N G Gavalas, M Tsiatas, O Tsitsilonis, et al.
Page
of 3